NASDAQ Companies

WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]

LAS VEGAS, Jan. 02, 2024 (GLOBE NEWSWIRE) — HF Foods Group Inc. (NASDAQ: HFFG) (“HF Foods” or the “Company”), a […]

NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]

ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) — Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is excited […]

LITTLE ROCK, Ark., Jan. 02, 2024 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) announced its Board of Directors […]

SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]

HAMILTON, Bermuda, Jan. 02, 2024 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at […]

SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company […]

New York, Jan. 02, 2024 (GLOBE NEWSWIRE) — Blue World Acquisition Corporation (the “Blue World”) (NASDAQ: BWAQ) today announced that, […]

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, […]